Profile data is unavailable for this security.
About the company
Hangzhou Biotest Biotech Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of point-of-care testing (POCT) diagnostic reagents. The Company's products include reproductive health testing series, such as human chorionic gonadotropin testing reagent and luteinizing hormone testing reagent, and drug abuse testing series, such as morphine testing reagent and cocaine testing reagent, and infectious disease testing series, such as adenovirus testing reagent and typhoid antibody testing reagent, and tumor marker testing series, such as alpha fetoprotein detection reagent, and myocardial marker detection series, such as dimer detection reagent and myocardial series detection reagent.
- Revenue in CNY (TTM)478.69m
- Net income in CNY102.57m
- Incorporated2008
- Employees603.00
- LocationHangzhou Biotest Biotech Co LtdNo. 27, Tuyi RoadCangqian Neighborhood, Yuhang DistrictHANGZHOU 311100ChinaCHN
- Phone+86 57 189058091
- Fax+86 57 189058091
- Websitehttps://www.biotests.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hangzhou Ags Medtech Co Ltd | 668.70m | 272.95m | 4.98bn | 744.00 | 18.19 | 2.00 | -- | 7.44 | 3.37 | 3.37 | 8.25 | 30.67 | 0.2673 | 3.31 | 11.94 | 898,793.60 | 10.91 | -- | 11.39 | -- | 69.67 | -- | 40.82 | -- | 18.27 | -- | 0.001 | -- | 25.14 | -- | 35.06 | -- | -- | -- |
| Zhejiang Orient Gene Biotech Co Ltd | 842.11m | -479.50m | 5.01bn | 2.28k | -- | 0.787 | -- | 5.94 | -2.48 | -2.48 | 4.37 | 31.55 | 0.107 | 1.44 | 3.39 | 369,997.60 | -6.68 | 21.19 | -7.77 | 26.74 | 34.88 | 58.52 | -62.43 | 32.42 | 3.86 | -- | 0.0462 | 24.78 | 0.946 | 17.65 | -33.06 | -- | 138.80 | -- |
| Assure Tech (Hangzhou) Co Ltd | 462.72m | 120.87m | 5.04bn | 741.00 | 41.72 | 0.9768 | -- | 10.90 | 0.9511 | 0.9511 | 3.64 | 40.62 | 0.0809 | 2.22 | 2.17 | 624,449.30 | 2.11 | 23.69 | 2.30 | 28.01 | 30.32 | 64.61 | 26.11 | 47.65 | 11.28 | -- | 0.0012 | 18.78 | 7.42 | 20.85 | 35.85 | 28.69 | 63.16 | -- |
| Nanjing Vishee Medical Technology Co Ltd | 433.83m | 125.95m | 5.42bn | 639.00 | 43.03 | 3.27 | -- | 12.49 | 1.32 | 1.32 | 4.53 | 17.31 | 0.2411 | 4.00 | 14.42 | 678,922.30 | 7.00 | 8.39 | 7.63 | 9.20 | 61.24 | 71.62 | 29.03 | 32.76 | 6.54 | -- | 0.0182 | 59.13 | -13.45 | 4.64 | -25.16 | 0.4474 | 39.73 | -- |
| Hangzhou Biotest Biotech Co Ltd | 478.69m | 102.57m | 5.44bn | 603.00 | 52.28 | 2.33 | -- | 11.36 | 0.6964 | 0.6964 | 3.06 | 15.66 | 0.1913 | 3.20 | 5.70 | 793,854.10 | 4.02 | 23.63 | 4.25 | 26.20 | 50.57 | 56.59 | 21.00 | 41.47 | 13.08 | -- | 0.00008 | 34.42 | 26.53 | 21.78 | 59.01 | 43.12 | 44.08 | -- |
| SWS Hemodialysis Care Co Ltd | 733.59m | 113.43m | 5.52bn | 1.10k | 48.84 | 3.13 | -- | 7.53 | 0.3538 | 0.3538 | 2.29 | 5.52 | 0.3577 | 2.80 | 6.23 | 665,688.20 | 5.23 | 5.68 | 5.83 | 6.54 | 45.71 | 45.79 | 14.61 | 16.06 | 5.25 | -- | 0.0014 | 28.46 | -17.80 | 31.86 | -63.55 | -- | 24.70 | -- |
| Shanghai Aohua Phtlctrcty Endscp Co Ltd | 671.62m | -72.38m | 5.76bn | 1.22k | -- | 4.62 | -- | 8.57 | -0.5475 | -0.5475 | 5.10 | 9.25 | 0.3834 | 1.02 | 2.29 | 552,775.60 | -4.14 | 3.01 | -5.15 | 3.34 | 61.79 | 68.86 | -10.80 | 7.52 | 1.57 | -- | 0.2086 | 43.30 | 10.54 | 20.28 | -63.68 | -16.86 | 23.29 | -- |
| Qingdao NovelBeam Technology Co Ltd | 571.80m | 174.33m | 5.85bn | 841.00 | 33.62 | 4.44 | -- | 10.23 | 1.45 | 1.45 | 4.76 | 10.99 | 0.3817 | 0.9932 | 5.67 | 679,901.10 | 11.39 | 12.70 | 12.61 | 14.11 | 64.34 | 63.15 | 29.84 | 33.96 | 3.43 | 51.04 | 0.1058 | 40.95 | -5.90 | 11.86 | -7.11 | 13.48 | 13.44 | -- |
| Jiangsu Bioperfectus Technologies Co Ltd | 339.03m | -25.96m | 5.88bn | 592.00 | -- | 1.98 | -- | 17.36 | -0.3096 | -0.3096 | 4.04 | 35.38 | 0.0903 | 1.85 | 6.13 | 572,683.70 | -0.6919 | 20.36 | -0.796 | 24.55 | 58.22 | 62.71 | -7.66 | 31.89 | 3.22 | -- | 0.1329 | 28.76 | -13.29 | 3.90 | 99.46 | -- | -9.88 | -- |
| Shenzhen Lifotronic Technology Co Ltd | 1.05bn | 251.02m | 5.93bn | 1.67k | 23.41 | 2.82 | -- | 5.62 | 0.5907 | 0.5907 | 2.47 | 4.90 | 0.3855 | 2.51 | 5.74 | 631,202.60 | 8.98 | 14.03 | 12.10 | 17.34 | 61.03 | 62.46 | 23.30 | 27.25 | 3.00 | -- | 0.1406 | 39.01 | 0.2024 | 22.12 | 5.12 | 27.99 | -1.63 | 18.64 |
Data as of Feb 11 2026. Currency figures normalised to Hangzhou Biotest Biotech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
9.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 4.24m | 2.84% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 3.01m | 2.01% |
| Origin Asset Management LLPas of 30 Jun 2025 | 2.20m | 1.47% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 1.55m | 1.04% |
| Manulife TEDA Fund Management Co., Ltd.as of 30 Jun 2025 | 1.21m | 0.81% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 1.14m | 0.76% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 145.46k | 0.10% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 110.45k | 0.07% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 36.12k | 0.02% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 27.07k | 0.02% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
